Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]

The summary for the Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44] Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.

	Federal Grant Title:	Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]
	CFDA Number:	93.396
	CFDA Description:	Cancer Biology Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-09-187
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	May 19, 2009
	Creation Date:	May 19, 2009
	Original Closing Date for Applications:	May 07, 2012
	Current Closing Date for Applications:	May 07, 2012
	Archive Date:	Jun 07, 2012
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	$200,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant

Small businesses

Additional Information on Eligibility

Information not provided

Grant Description

Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), at the National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) propose to develop new technologies and/or improve existing technologies for the detection and evaluation of chemical and biological carcinogens in clinical and/or environmental specimens. These technologies should be amenable to automation and high sample throughput. The ultimate goal of this initiative is to develop innovative carcinogen detection technologies to the stage of commercially viable assays. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Other related FOAs that also use the SBIR mechanism are PA-09-188 and PA-09-189. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.

Link to Full Grant Announcement

http://grants.nih.gov/grants/guide/pa-files/pa-09-187.html

Grant Announcement Contact

NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]

Similar Government Grants

• The Biology of Estrogen Receptor-Negative Breast Cancer in Various Racial and Ethnic Groups (U01)

• Technologies and Software to Support Integrative Cancer Biology Research (SBIR) [R43/R44]

• The Integrative Cancer Biology Program (ICBP): Centers for Cancer Systems Biology (CCSB) (U54)

• Memory T Lymphocytes in Cancer Immunology (R01)

• Basic Research in the Bladder and Lower Urinary Tract (R01)

• MOUSE MODELS OF HUMAN CANCERS CONSORTIUM

• INTEGRATIVE CANCER BIOLOGY PROGRAMS

• Memory T Lymphocytes in Cancer Immunology (R21)